Eli Lilly and Company (LLY) — closed signal from April 1, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on June 30, 2026.
Predicted vs. what happened
LLY price · publication thesis → realized outcomesplit-adjusted
$920.00 – $940.00Entry zone — fair-value band
$933.83Published — price the day we called it
$1,036.55Target — the price the thesis aimed for
$1,238.00Peak — highest point inside the window, not a realized return
$1,229.93Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 49 days.
Peak price
$1,238.00
peak on June 29, 2026 — not a realized returnPeak gain
+32.6%
peak, from the publication priceWindow close
$1,229.93
end-of-window price, context onlyDays to target
49
Window
April 1, 2026 – June 30, 2026
The thesis — published April 1, 2026
Predicted growth
+11%
over the measurement windowTarget price
$1,036.55
the price the thesis aimed forEntry zone
$920.00 – $940.00
the fair-value band we waited forPrice at publication
$933.83
published April 1, 2026Confidence
78%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Eli Lilly is kept high on the short-term list because it mixes steady healthcare demand with ongoing growth. The stock is holding near its trend instead of falling apart, and recent commentary suggests it may be slightly undervalued. Interest in GLP-1 drugs helps the story, but sentiment is already strong, so gains may come gradually rather than in a quick surge.
Primary drivers
- Strong sales from diabetes and obesity medicines keep revenue growing
- Healthcare stability helps offset market swings
- Recent valuation notes suggest shares may be reasonably priced
- Company operations and reporting have remained consistent and reliable
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.